Lipoprotein Apheresis and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Do We Have a Vanquishing New Strategy?
European Journal of Preventive Cardiology - United Kingdom
doi 10.1177/2047487318817671
Full Text
Open PDFAbstract
Available in full text
Date
December 5, 2018
Authors
Publisher
SAGE Publications